jueves, 6 de febrero de 2025
Personalized cancer vaccine shows potential in kidney cancer Nine patients were cancer-free after three years, small study says
https://www.statnews.com/2025/02/05/personalized-cancer-vaccine-kidney-dana-farber-yale/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_KA5zKgL7M39pd61GoKeUKaa5QslDswjpUpFQqKYqgq0xH5NqeW_jQXSQ6IeJfv7uEXis3DOzR9jS25pmMUrsM60TdZA&_hsmi=345985342&utm_content=345985342&utm_source=hs_email
Some good news re: a cancer vaccine
Nine patients with advanced kidney cancer who received an experimental vaccine tailored to their tumors’ specific mutations mounted an immune response to their disease and have remained cancer-free for three years, an early-phase clinical trial has shown.
Cancer vaccines developed with different molecular recipes are still in their early stages, experts told STAT’s Liz Cooney. The study demonstrates the potential of personalized vaccines to change the course of certain cancer types, but larger, longer trials are needed to confirm this approach. Read more on the science.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario